TY - JOUR
T1 - DIFFUSE LARGE CELL LYMPHOMA
T2 - A TEACHING HOSPITAL EXPERIENCE
AU - ELLIS, D.
AU - MARKS, D.
AU - SHERIDAN, W.
AU - GREEN, M.
AU - FOX, R.
AU - BOYD, A.
AU - MORSTYN, G.
PY - 1989/4
Y1 - 1989/4
N2 - Improvement in the treatment of diffuse large cell lymphoma (DLCL) over the last 15 years has been one of the notable successes of modern chemotherapy. This paper reports a three year experience (1985–87) of 46 unselected consecutive patients with DLCL in a single teaching hospital. A striking finding was that visceral, extranodal presentations were disproportionately common. The excellent response of stage I patients to chemotherapy alone is emphasised as is the role of immunophenotyping in diagnosis.
AB - Improvement in the treatment of diffuse large cell lymphoma (DLCL) over the last 15 years has been one of the notable successes of modern chemotherapy. This paper reports a three year experience (1985–87) of 46 unselected consecutive patients with DLCL in a single teaching hospital. A striking finding was that visceral, extranodal presentations were disproportionately common. The excellent response of stage I patients to chemotherapy alone is emphasised as is the role of immunophenotyping in diagnosis.
UR - http://www.scopus.com/inward/record.url?scp=0024414738&partnerID=8YFLogxK
U2 - 10.1111/j.1445-5994.1989.tb00233.x
DO - 10.1111/j.1445-5994.1989.tb00233.x
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 2475099
AN - SCOPUS:0024414738
SN - 0004-8291
VL - 19
SP - 159
EP - 161
JO - Australian and New Zealand Journal of Medicine
JF - Australian and New Zealand Journal of Medicine
IS - 2
ER -